Even more is that ~40-45% of patients lost at least 30% of their body weight and about 1 in 4 lost more than 35% of their body weight
[10] [12] Benzyl alcohol toxicity is a recognised clinical concern in vulnerable populations, as noted in BNF guidance and MHRA product information
Each cycle of loss and regain may worsen metabolic adaptation, making subsequent weight loss harder and regain faster
The 98-participant trial used liver fat content, assessed by MRI-derived proton density fat fraction (MRI-PDFF), as the primary endpoint at 24 weeks
In May 2025, CheqUp, based in the UK, and WeightWatchers teamed up to offer clinical GLP-1 medication support along with behavioral lifestyle programs
The incidence of adverse side effects was similar between GLP-1 and gliptin groups